FemBloc® Permanent Contraception - Early Pivotal Trial

Completed · Not applicable

Conditions studied: Contraception

In brief

Prospective, multi-center, international, non-randomized, two-arm study of subjects undergoing either FemBloc or laparoscopic bilateral tubal sterilization (Control). The FemBloc group total study duration will be approximately 65 months. The laparoscopic tubal sterilization (Control) group total study duration will be approximately 62 months.

Key facts

Study ID
NCT03433911
Run by
Femasys Inc.
People needed
240
Starts
2018-02-02
Expected to finish
2025-02-10
Last updated by the study team
2026-02-27

Who can join

Age: 21 and older, up to 45. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.